Craft

Advanced Proteome Therapeutics

Stock Price

$0

2023-07-17

Market Capitalization

$822.5 K

2023-07-17

Advanced Proteome Therapeutics Summary

Company Summary

Overview
Advanced Proteome Therapeutics is a company that develops a proprietary technology to target cancerous tumors and avoid destroying normal cells. Its approach promotes the production and targeted delivery of anti-cancer drugs to cancerous tumors avoiding the side effects of traditional chemotherapeutics.
Type
Public
Status
Active
Founded
2007
HQ
Boston, MA, US | view all locations
Website
https://www.advancedproteome.com
Cybersecurity rating
Sectors

Key People

  • Bill Dickie, Chief Executive Officer, President, and Director

    • Benjamin Krantz

      Benjamin Krantz, Director

      • Paul Woodward

        Paul Woodward, Director

        LocationsView all

        1 location detected

        • Boston, MA HQ

          United States

          650 Albany St #109

        Footer menu